Elsaka, Omar and Noureldean, Moneer Ayman and Gamil, Mohamed Adel and Ghazali, Mostafa Tarek and Al-Razik, Ashraf Hamada Abd and Hisham, Dalia (2021) Egypt Fights Spinal Muscular Atrophy. Asian Journal of Research and Reports in Neurology, 4 (2). pp. 122-124.
39-Article Text-67-1-10-20220901.pdf - Published Version
Download (203kB)
Abstract
SMA (spinal muscular atrophy) is a neuromuscular illness caused by a genetic (inherited) mutation that causes muscles to weaken and waste away. Motor neurons, a type of nerve cell in the spinal cord that controls muscle movement, are lost in people with SMA. Many pharmaceutical companies continue to invest heavily in research into SMA therapies. Many additional prospective medications, such as valproic acid, phenylbutyrate, hydroxyurea, albuterol, gabapentin, riluzole, olesoxime, and rapamycin, have failed to generate adequate outcomes regarding disease progression.
Item Type: | Article |
---|---|
Subjects: | Afro Asian Archive > Medical Science |
Depositing User: | Unnamed user with email support@afroasianarchive.com |
Date Deposited: | 05 Apr 2023 06:52 |
Last Modified: | 29 Jul 2024 11:17 |
URI: | http://info.stmdigitallibrary.com/id/eprint/206 |